Exchange: NASDAQ·Updated 03:05 PM EDT
AUPH logo

AUPH Aurinia Pharmaceuticals Inc

$16.17
$0.045
(0.28%)
Today
Reported EarningsAug 6
Mkt Cap$2.14B
Vol273,523.00

About AUPH

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.
47

Neutral Sentiment

How do you feel about AUPH?

Advertisement|Remove ads.